Quality of Care in the Last Two Years of Life for Children with Complex Chronic Conditions.

complex chronic conditions end-of-life palliative care pediatric quality improvement

Journal

Journal of pain and symptom management
ISSN: 1873-6513
Titre abrégé: J Pain Symptom Manage
Pays: United States
ID NLM: 8605836

Informations de publication

Date de publication:
01 Aug 2024
Historique:
received: 27 06 2024
revised: 25 07 2024
accepted: 29 07 2024
medline: 4 8 2024
pubmed: 4 8 2024
entrez: 3 8 2024
Statut: aheadofprint

Résumé

Limited data exists about care received by children with complex chronic conditions (CCCs) in the final years of their disease and end-of-life (EOL). To examine hospital performance on EOL quality measures and to describe healthcare services during the last two years of life for children with CCCs who died in-hospital. Retrospective automated electronic health record review of children with ≥1 CCC ICD-10 diagnosis code, who died inpatient between October 2020-March 2023 at a single quaternary U.S. children's hospital. Quality was assessed based on performance on 15 measures across 5 domains: healthcare utilization, interprofessional supports, medical intensity, symptom management, and communication. Quality EOL care and healthcare services in the last two years of life were determined overall by age group and per patient. Descriptive statistics were used to evaluate demographic differences by age. 266 children with CCCs died in the study timeframe; 45% were infants (n=120), 52% (n=137) were male, 42% (n=113) were white, 64% (n=170) were non-Hispanic, and 59% (n=156) had public insurance. Children had a median of 3 CCCs (IQR 2.4; range 1-8). On average, children met 69% (SD 13%) of EOL quality measures for which they were eligible. In the 2 years prior to death, 98% (n=261) had an ICU admission, 75% (n=200) had a procedure requiring sedation, and 29% (n=79) had received cardiopulmonary resuscitation. 86% (n=229) died in the ICU. In this study, children with CCCs met 69% of quality measures and received high-intensity healthcare in the last 2 years of life.

Identifiants

pubmed: 39097243
pii: S0885-3924(24)00910-2
doi: 10.1016/j.jpainsymman.2024.07.034
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Conflict of Interest Disclosures The authors have no conflict of interest to disclose.

Auteurs

Jori F Bogetz (JF)

Division of Bioethics and Palliative Care, Department of Pediatrics, University of Washington School of Medicine; Center for Clinical and Translational Research, Seattle Children's Research Institute. Electronic address: jori.bogetz@seattlechildrens.org.

Bryan Strub (B)

Biostatistics, Epidemiology and Analytics in Research (BEAR) Core, Seattle Children's Research Institute; 1920 Terry Ave, Seattle, WA 98101, United States. Electronic address: Bryan.Strub@seattlechildrens.org.

Miranda C Bradford (MC)

Biostatistics, Epidemiology and Analytics in Research (BEAR) Core, Seattle Children's Research Institute; 1920 Terry Ave, Seattle, WA 98101, United States. Electronic address: miranda.bradford@seattlechildrens.org.

Julie McGalliard (J)

Biostatistics, Epidemiology and Analytics in Research (BEAR) Core, Seattle Children's Research Institute; 1920 Terry Ave, Seattle, WA 98101, United States. Electronic address: julie.mcgalliard@seattlechildrens.org.

Kelly Shipman (K)

Palliative Care and Resilience Lab, Seattle Children's Research Institute; Center for Clinical Immunotherapies, University of Pennsylvania; 3400 Civic Center Blvd, Philadelphia, PA 19104, United States. Electronic address: Kelly.Shipman@pennmedicine.upenn.edu.

Astan Jeyte (A)

Behavioral and Clinical Outcomes Research Program, Seattle Children's Research Institute; Office: 1920 Terry Avenue, Seattle WA 98101, United States. Electronic address: Astan.Jeyte@seattlechildrens.org.

Arika Patneaude (A)

Division of Bioethics and Palliative Care, Seattle Children's Hospital; Treuman Katz Center for Pediatric Bioethics and Palliative Care, Seattle Children's Research Institute; University of Washington School of Social Work. Electronic address: arika.patneaude@seattlechildrens.org.

Emily E Johnston (EE)

Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of Alabama at Birmingham School of Medicine; Institute for Cancer Outcomes and Survivorship, UAB School of Medicine. Electronic address: eejohnston@uabmc.edu.

Prasanna Ananth (P)

Department of Pediatrics, Yale School of Medicine, Yale Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center. Electronic address: prasanna.ananth@yale.edu.

Rachel Thienprayoon (R)

University of Cincinnati College of Medicine; Department of Anesthesia, Division of Palliative Care, Cincinnati Children's Hospital Medical Center. Electronic address: Rachel.thienprayoon@cchmc.org.

Abby R Rosenberg (AR)

Department of Psychosocial Oncology and Palliative Care, Dana Farber Cancer Institute; Department of Pediatrics, Boston Children's Hospital; Department of Pediatrics Harvard Medical School. Electronic address: abbyr_rosenberg@dfci.harvard.edu.

Classifications MeSH